🔴 < Other Devices
Bladder cancer evaluation requires accurate assessment of tumour invasion, heterogeneity, and response to treatment. While MRI provides valuable anatomical and functional information, its interpretation remains challenging and often dependent on qualitative assessment.
Kenko Bladder is designed to convert multiparametric bladder MRI into quantitative, explainable imaging biomarkers that help radiologists better understand tumour behaviour. By supporting more objective characterisation and reducing variability, it strengthens clinical confidence in staging, treatment planning, and follow-up.
Built on Kenko Imalytics’ core technology, these solutions transform multiparametric MRI into quantitative, explainable imaging biomarkers derived from perfusion, diffusion, and anatomical context. By integrating vascular dynamics, tissue cellularity, and structural information, Kenko enables a more complete and clinically interpretable understanding of tumour behaviour, supporting clearer, more consistent decision-making across the oncology pathway.
Kenko Bladder is currently under development.
Liver MRI plays a critical role in detecting and characterising focal lesions, yet differentiating between benign and malignant findings, and assessing tumour heterogeneity, remains complex in daily practice.
Kenko Liver is designed to support radiologists by transforming multiparametric liver MRI into quantitative, explainable imaging biomarkers. By revealing underlying tumour behaviour and improving lesion characterisation, it supports more confident diagnosis, treatment selection, and monitoring.
Built on Kenko Imalytics’ core technology, these solutions transform multiparametric MRI into quantitative, explainable imaging biomarkers derived from perfusion, diffusion, and anatomical context. By integrating vascular dynamics, tissue cellularity, and structural information, Kenko enables a more complete and clinically interpretable understanding of tumour behaviour, supporting clearer, more consistent decision-making across the oncology pathway.
Kenko Liver is currently under development.
Rectal cancer management relies heavily on MRI to stage disease, assess tumour extension, and guide treatment decisions. However, interpretation remains complex and variable, particularly in evaluating tumour aggressiveness, treatment response, and surgical margins.
Kenko Rectum is designed to support radiologists by transforming multiparametric rectal MRI into quantitative, explainable imaging biomarkers. By providing objective insight into tumour behaviour and tissue characteristics, it enables more consistent staging, improved treatment planning, and clearer multidisciplinary decision-making.
Built on Kenko Imalytics’ core technology, these solutions transform multiparametric MRI into quantitative, explainable imaging biomarkers derived from perfusion, diffusion, and anatomical context. By integrating vascular dynamics, tissue cellularity, and structural information, Kenko enables a more complete and clinically interpretable understanding of tumour behaviour, supporting clearer, more consistent decision-making across the oncology pathway.
Kenko Rectum is currently under development.
Your login details have been sent to the email address linked to your authorised account. Please
follow the instructions included in that email to
access the platform securely.
Thank you.